Biotech giant trims jobs, but says Horizon closing is on track Amgen's new research and development facility in San Francisco. (courtesy photo) Amgen shares are down 4% as of Feb. 1, a couple of days after the giant biotechnology announced a decent layoff and one day after its earnings release for the fourth quarter and…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
